Patients with acute pancreatitis, bacterial peritonitis, adult respiratory distress syndrome (ARDS), septic shock, and arthritis all display extraordinarily high blood levels of secretory phospholipase A2 (s-PLA2). 1 The in vivo trigger for s-PLA2 release under such conditions is mediated by a number of mechanisms, all of which have been investigated as a primary site for drug discovery. However, it is believed that potent and selective inhibitors of s- ...